Table I.
Clinical and laboratory parameters of AML ND patients.
| Patient no. | Gender/age (years) | WBC (109/l) | NEU (109/l) | Marrow blast (%) | Blood blast (%) |
|---|---|---|---|---|---|
| 1 | F/25 | 70.55 | 96 | 28 | |
| 2 | F/56 | 52.25 | 35.62 | 80 | 66 |
| 3 | F/46 | 0.85 | 0.16 | 95 | 11 |
| 4 | F/56 | 1.81 | 0.05 | 78 | 68 |
| 5 | M/45 | 2.89 | 0.17 | 70 | 30 |
| 6 | F/56 | ||||
| 7 | F/80 | 1.97 | 0.56 | 28 | |
| 8 | F/74 | 2.16 | 1.29 | 54 | 3 |
| 9 | F/40 | 25.3 | 11.3 | 68 | 32 |
| 10 | F/32 | 1.28 | 0.27 | 37.50 | 6 |
| 11 | F/15 | 4.58 | 0.03 | 53.50 | 51 |
| 12 | M/61 | 4.58 | 2.95 | 94 | 64 |
| 13 | M/76 | 196.57 | 98 | 92 | |
| 14 | M/69 | 16.16 | 3.49 | 93 | 82 |
| 15 | M/40 | 76.67 | 20.72 | 85 | 75 |
| 16 | M/21 | 45.06 | 18.74 | 44 | 40 |
| 17 | F/59 | 4.14 | 0.3 | 58 | 36 |
| 18 | F/53 | 123.3 | 28.83 | 71 | 64 |
| 19 | M/44 | 11.7 | 45.2 | 13 | 70 |
| 20 | M/21 | 24.77 | 75.8 | 79 | 68 |
| 21 | M/29 | 105.4 | 50.5 | 86 | 95 |
| 22 | F/45 | 97.81 | 5.3 | 96 | 95 |
| 23 | M/42 | 5.03 | 10.2 | 70 | 34 |
| 24 | M/55 | 66.25 | 15.54 | 80 | 80 |
| 25 | M/20 | 39.32 | 1.25 | 95 | 93 |
| 26 | F/49 | 5.1 | 3.58 | 86 | 65 |
| 27 | F/47 | 6.91 | 5.42 | 95 | 65 |
AML, acute myeloid leukemia; ND, newly diagnosed; WBC, white blood cell; NEU, neutrophil.